|
|
|
May 19, 2004
Features
Robots are invading every aspect of discovery and development, from genotyping to high-throughput screening.
By Malorye A. Branca
Not every clinical trial on the planet is ready for electronic data capture.
By Mark D. Uehling
| Strategic Insights: Economic Development |
|
| · |
Novartis expands in the Northeast.
By Barbara Depompa |
| · |
The Danforth Center takes root in St. Louis.
By Barbara Depompa |
| · |
Lexicon helps put the "tech" in Texas.
By Barbara Depompa |
| · |
Seattle Genetics predicts a sunny future.
By Barbara Depompa |
Horizons
Conversation: Mark Murcko
Vertex Pharmaceuticals' Mark Murcko discusses open source, buying versus building, and ROI on IT.
Market Compass
Bland first quarter in 2004 was punctuated by Human Genome Sciences mini-drama.
Guest Commentary
Extensible languages can help eliminate automation workflow bottlenecks in the laboratory.
Departments
News & Analysis
Including Bio-IT World Conference + Expo Report
FDA: Help Us Plot Act Two for Part 11
Keynoters Focus on Challenges Ahead
Your Genome on Drugs
Best of Show – March Madness, Bio-IT World Style
A Question of Standards
Stein Wins Franklin Award
Following the Money
Beyond Heavy Metal
Bringing Informatics to Life
Columns
First Base | Kevin Davies
TAT tagging has aroused keen interest in biotech.
Inside the Box | Michael Athanas
Transforming a cluster into a digital rendering farm.
Fully Equipped | Julia Boguslavsky
Microfluidics offers alternatives to conventional HTS.
The Russell Transcript | John Russell
A tiny clearing in the fog of systems biology.
|
|
|
|